Reporter July 16 2021

Update on COVID-19 for VUMC workforce: what you need to know

COVID-19 is still very much part of our daily lives, and infection rates are on the increase in the community. VUMC continues to effectively manage COVID-19, and outpatient and inpatient volumes are back to pre-COVID levels.

Jaser to lead new Pediatric Psychology division

Sarah Jaser, PhD, associate professor of Pediatrics, has been named the inaugural director for the new Division of Pediatric Psychology within the Department of Pediatrics.

Shichun Bao, MD, PhD, center, and Brenda Weedman, RN, BSN, discuss continuous glucose monitors with patient Sherry Neergaard.

Study shows continuous glucose monitors improve management of type 2 diabetes

For patients with type 2 diabetes treated with basal or long-acting insulin, the use of continuous glucose monitors (CGMs) can result in significantly lower hemoglobin A1C (a blood test that reflects average blood glucose levels over three months), and better management of the disease according to a study recently published in the journal JAMA.

Arterial stiffening linked to Alzheimer’s disease

A research team from Vanderbilt University Medical Center reports in Neurology that greater stiffening of the aorta, the main artery in the human body, is associated in older adults with increased Alzheimer’s disease (AD) pathology as reflected in a range of neurochemical indicators measured in cerebrospinal fluid.

Members of the Osher Center for Integrative Medicine at Vanderbilt recently celebrated receiving an additional grant from the Bernard Osher Foundation.

Grant bolsters Osher Center for Integrative Medicine

The Bernard Osher Foundation has given an additional $2.1 million to the Osher Center for Integrative Medicine at Vanderbilt. This grant supplements the original endowment established in 2014 through the Bernard Osher Foundation’s leadership and commitment to holistic medicine.

Susan G. Komen funds VICC breast cancer initiatives

Susan G. Komen has announced breast cancer research grants totaling $14 million, including funding for three separate initiatives led by Vanderbilt-Ingram Cancer Center (VICC) researchers.